US Dollar vs MXN

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

EWTX Edgewise Therapeutics Inc

28.60

-0.14 (-0.49%)

Pre Mercado

Última actualización: 07:40:25

Retrasado por 15 minutos

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

09/20/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Alan J Russell

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Edgewise Therapeutics (NASDAQ:EWTX)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024

Haga Click aquí para más Gráficas Edgewise Therapeutics.

Edgewise Therapeutics (NASDAQ:EWTX)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024

Haga Click aquí para más Gráficas Edgewise Therapeutics.

Noticias sobre Edgewise Therapeutics Inc EWTX

Form 8-K - Current report
Lunes 16 de Diciembre 2024 (2 semanas hace) • Edgar (US Regulatory)

Edgewise Therapeutics Announces Positive Topline Results from the CANYON Phase 2 Trial of Sevasemten in Individuals with Becker Muscular Dystrophy (Becker)
Lunes 16 de Diciembre 2024 (2 semanas hace) • Business Wire

Edgewise Provides Statement Regarding Company’s Relationship with Dr. Han Phan at Rare Disease Research
Jueves 5 de Diciembre 2024 (4 semanas hace) • Business Wire

Edgewise Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024
Martes 26 de Noviembre 2024 (1 mes hace) • Business Wire

Form S-8 - Securities to be offered to employees in employee benefit plans
Jueves 7 de Noviembre 2024 (2 meses hace) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jueves 7 de Noviembre 2024 (2 meses hace) • Edgar (US Regulatory)

Form 8-K - Current report
Jueves 7 de Noviembre 2024 (2 meses hace) • Edgar (US Regulatory)

Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Jueves 7 de Noviembre 2024 (2 meses hace) • Business Wire

Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society
Martes 1 de Octubre 2024 (3 meses hace) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Martes 24 de Septiembre 2024 (3 meses hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Martes 24 de Septiembre 2024 (3 meses hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Viernes 20 de Septiembre 2024 (3 meses hace) • Edgar (US Regulatory)

Más de Edgewise Therapeutics Inc Artículos de Noticias

Stand.crt.prp.r

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones